| Crude | Adjusted†| ||
---|---|---|---|---|
Variable | HR | (95%CI) | HR | (95%CI) |
Sex | ||||
Women | 1.00 | Â | 1.00 | Â |
Men | 0.94 | (0.89-1.00) | 0.97 | (0.92-1.03) |
Age, years | ||||
20–39 | 1.00 |  | 1.00 |  |
40–64 | 19.7 | (10.2-38.0) | 16.1 | (8.35-31.2) |
≥65 | 216 | (112.-414) | 133 | (68.9-256) |
CKD | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.68 | (1.58-1.78) | 1.41 | (1.32-1.50) |
Hypertension | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 4.10 | (3.85-4.37) | 1.17 | (1.09-1.26) |
Diabetes mellitus | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 2.14 | (2.00-2.28) | 1.25 | (1.17-1.34) |
Ischemic heart disease | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 3.11 | (2.94-3.30) | 1.00 | (0.93-1.06) |
Hyperlipidemia | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.35 | (1.25-1.45) | 0.89 | (0.83-0.97) |
Tobacco use disorder | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.00 | (0.48-2.09) | -- | Â |
Alcoholism | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.78 | (1.27-2.49) | 3.05 | (2.17-4.28) |
Obesity | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 0.64 | (0.41-1.00) | 0.93 | (0.59-1.46) |
Atrial fibrillation | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 3.77 | (3.19-4.45) | 1.17 | (0.99-1.39) |
Parkinson's disease | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 6.92 | (6.13-7.82) | 1.80 | (1.59-2.04) |
Cerebrovascular disease | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 4.85 | (4.57-5.14) | 1.72 | (1.61-1.84) |
Major depressive disorder | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 2.68 | (2.26-3.17) | 1.95 | (1.64-2.31) |
Use of benzodiazepine | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 2.54 | (2.37-2.71) | 1.23 | (1.14-1.32) |
Use of aspirin | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.85 | (1.71-2.00) | 1.02 | (0.95-1.11) |
Use of other NSAIDs | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 1.54 | (1.39-1.70) | 1.01 | (0.91-1.12) |
Use of COX2 | ||||
No | 1.00 | Â | 1.00 | Â |
Yes | 2.45 | (2.31-2.60) | 1.09 | (1.02-1.16) |